MiNK Therapeutics shares surged 70% in pre-market trading after the company announced that its partner C-Further received up to $1.1 million in funding to advance pediatric cancer cell therapy research.

MiNK Therapeutics shares surged 70% in pre-market trading after the company announced that its partner C-Further received up to $1.1 million in funding to advance pediatric cancer cell therapy research.

老虎证券2026/03/10 10:41

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This funding will accelerate C-Further's research progress in the field of pediatric cancer cell therapy and provide strong support for the technological development of MiNK Therapeutics. The market has responded positively to this news, demonstrating investors' optimism about the company's future prospects.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MiNK Therapeutics shares surged 70% in pre-market trading after the company announced that its partner C-Further received up to $1.1 million in funding to advance pediatric cancer cell therapy research.

You may also like

Crypto prices